DexCom Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,662	4,033	3,622	2,910	2,449
Revenue Growth (YoY)	15.60%	11.34%	24.49%	18.84%	27.08%
Cost of Revenue	1,860	1,595	1,333	1,027	768
Gross Profit	2,802	2,438	2,289	1,883	1,681
Selling, General & Admin	1,291	1,286	1,185	1,008	810.5
Research & Development	599.1	552.4	505.8	484.2	604.2
Operating Expenses	1,890	1,838	1,691	1,492	1,415
Operating Income	911.8	600	597.7	391.2	265.8
Interest Expense	-18.3	-19	-20.3	-18.6	-18.8
Interest & Investment Income	112.7	134.2	135	23.8	1.7
Other Non Operating Income (Expenses)	82.2	-6.2	-2	-5.6	-3.4
EBT Excluding Unusual Items	1,088	709	710.4	390.8	245.3
Gain (Loss) on Sale of Investments	-	-	-	-	11.6
Other Unusual Items	-	-	-	-	-0.1
Pretax Income	1,088	709	710.4	390.8	256.8
Income Tax Expense	252.1	132.8	168.9	49.6	39.9
Net Income	836.3	576.2	541.5	341.2	216.9
Net Income to Common	836.3	576.2	541.5	341.2	216.9
Net Income Growth	45.14%	6.41%	58.70%	57.31%	-60.54%
Shares Outstanding (Basic)	390	394	386	389	387
Shares Outstanding (Diluted)	406	413	426	428	429
Shares Change (YoY)	-1.75%	-3.01%	-0.47%	-0.30%	2.00%
EPS (Basic)	2.14	1.46	1.40	0.88	0.56
EPS (Diluted)	2.09	1.42	1.30	0.82	0.53
EPS Growth	46.73%	9.35%	58.06%	54.74%	-60.09%
Free Cash Flow	1,077	630.7	511.9	304.7	53.3
Free Cash Flow Per Share	2.66	1.53	1.20	0.71	0.12
Gross Margin	60.10%	60.46%	63.19%	64.72%	68.63%
Operating Margin	19.56%	14.88%	16.50%	13.44%	10.86%
Profit Margin	17.94%	14.29%	14.95%	11.73%	8.86%
Free Cash Flow Margin	23.11%	15.64%	14.13%	10.47%	2.18%
EBITDA	1,164	817.7	783.7	547.1	367.8
EBITDA Margin	24.96%	20.28%	21.63%	18.80%	15.02%
D&A For EBITDA	251.8	217.7	186	155.9	102
EBIT	911.8	600	597.7	391.2	265.8
EBIT Margin	19.56%	14.88%	16.50%	13.44%	10.86%
Effective Tax Rate	23.16%	18.73%	23.77%	12.69%	15.54%
Advertising Expenses	223.8	194.2	180.8	160.6	150.1

Updated Feb 12, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q